General
Glimepiride carries added hypoglycaemia risk in certain elderly patients with T2D
 

Glimepiride carries added hypoglycaemia risk in certain elderly patients with T2D

Shared by:

 
The sulfonylurea glimepiride may pose an increased risk of hypoglycaemia in a subgroup of elderly type 2 diabetes (T2D) patients with lower β-cell function when added to a metformin regimen, according to a post-hoc analysis of data from the GENERATION* trial.
 
specialty.mims.com
 
9 Jan 2017 - General
 
Glimepiride and metformin combination therapy is widely used in India for management of type 2 diabetes. The study showing that hypoglycemia is more seen in old age patients with age more than 75 years and also significant between ages of 65-75 year...
 (Total 90 words)
In my practice everyday in the wards, we will never miss patients who are diabetic. May it be juvenile diabetes mellitus, type 1 or 2 diabetes mellitus and gestational diabetes mellitus. This has been a very sensational condition accross all groups a...
 (Total 91 words)